FDA Approved: TERCONAZOLE VAGINAL CREAM 0.8% — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Terconazole vaginal cream 0.8% from E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• TERCONAZOLE VAGINAL CREAM 0.8% (terconazole)

Snippet

SUPPL AP for TERCONAZOLE VAGINAL CREAM 0.8% (TERCONAZOLE)